SHUKRA PHARMACEUTICALS
|
The Current P/E Ratio of SHUKRA PHARMACEUTICALS is 103.90.
Share Price | ₹24.0 | Aug 25,2025 |
Market Cap | ₹1,051.4 Cr | |
Earnings-TTM | ₹10.1 Cr | TTM-Standalone Results |
Price/Earnings | 103.90x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SHUKRA PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,051.4 Cr] as on Aug 25,2025
(/) Earnings [ ₹10.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 103.90x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay 103.90 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHUKRA PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SHUKRA PHARMACEUTICALS
PE Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 11.80x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 4.82x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2020 at 42.79x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 1.04x.
How does SHUKRA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SHUKRA PHARMACEUTICALS | 10.12 | 103.90 | 1,051.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 38.18 | 397,498.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 71.92 | 165,838.0 |
CIPLA LTD | 5,406.81 | 23.92 | 129,330.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 62.06 | 124,235.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.72 | 107,211.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.39 | 105,553.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.20 | 102,978.0 |
LUPIN LTD | 3,722.18 | 24.11 | 89,724.9 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.14 | 61,991.9 |
ABBOTT INDIA LTD | 1,452.29 | 46.13 | 66,994.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHUKRA PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.14x |
Max industry PE | 103.90x |
Median industry PE | 38.18x |
Average industry PE | 44.06x |
You may also like the below Video Courses